You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
大成生化科技(00809.HK)預期債務重組計劃年底前取得進一步進展
阿思達克 03-08 17:35
大成生化科技(00809.HK)公佈,進出口銀行已將其於長春大合貸款及大成生物科技貸款項下的所有權益及利益以及相關擔保文件轉讓予新債權人中國信達資產管理股份有限公司吉林省分公司。 公司指,於進出口銀行轉讓貸款轉讓完成後,管理層將繼續與新債權人討論債務重組的下一步。董事會認爲,進出口銀行轉讓貸款之轉讓標誌着債務重組計劃取得令人滿意的進展。目前預期債務重組計劃將於2022年底前取得進一步進展,惟須待相應債權人及相關地方政府機構的內部審批。
Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account